4.1 Article

Management of clinically non-functioning pituitary adenoma

期刊

ANNALES D ENDOCRINOLOGIE
卷 76, 期 3, 页码 239-247

出版社

MASSON EDITEUR
DOI: 10.1016/j.ando.2015.04.002

关键词

Non-functioning pituitary adenoma; Gonadotroph adenoma; Silent pituitary adenoma; Pituitary apoplexy; Pituitary incidentaloma; Non-secreting pituitary adenoma; Pituitary surgery; Radiation therapy

向作者/读者索取更多资源

Clinically NFPA is currently the preferred term for designing all the pituitary adenomas which are not hormonally active (in other words, not associated with clinical syndromes such as amenorrhea-galactorrhea in the context of prolactinomas, acromegaly, Cushing's disease or hyperthyroidism secondary to TSH-secreting adenomas). They account for 15-30% of pituitary adenomas. Diagnosis is usually made either in the context of mass effect due to a macroadenoma or, increasingly, fortuitously during imaging performed for some unrelated purpose; the latter case is known as pituitary incidentaloma. Surgery is indisputably indicated in case of tumoral syndrome, but other aspects of NFPA (hormonal work-up, follow-up, and especially postoperative follow-up, management of remnant or recurrence, the special case of incidentaloma, or apoplexy) remain controversial. The French Endocrinology Society (SFE) therefore set up an expert working group of endocrinologists, neurosurgeons, ophthalmologists, neuroradiologists, pathologists and biologists to draw up guidelines, at the 2012 SFE Congress in Toulouse, France. The present article presents the guidelines suggested by this group of French-speaking experts. (C) 2015 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Endocrinology & Metabolism

Osilodrostat in Cushing's disease: The risk of delayed adrenal insufficiency should be carefully monitored

Frederic Castinetti, Vincent Amodru, Thierry Brue

Summary: This short manuscript reports three cases of atypical adrenal insufficiency with osilodrostat, which is highly effective in blocking cortisol secretion but also carries the risk of adrenal insufficiency.

CLINICAL ENDOCRINOLOGY (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Artificial intelligence in adrenal imaging: A critical review of current applications

Maxime Barat, Martin Gaillard, Anne-Segolene Cottereau, Elliot K. Fishman, Guillaume Assie, Anne Jouinot, Christine Hoeffel, Philippe Soyer, Anthony Dohan

Summary: In the field of adrenal imaging, artificial intelligence (AI) can be used for lesion detection, characterization, syndrome management, and patient follow-up. Although a perfect AI tool that covers all necessary steps from detection to analysis does not yet exist, multiple AI algorithms have been developed and tested with promising outcomes. However, AI in this setting is still in its early stages, and most published studies on AI in adrenal gland imaging provide preliminary results that have not yet found daily applications in clinical practice. This review presents recent developments and current results of AI in adrenal imaging and discusses the limitations and future perspectives of AI.

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2023)

Correction Oncology

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 31, pg 1476, 2020)

M. Fassnacht, G. Assie, E. Baudin, G. Eisenhofer, C. de la Fouchardiere, H. R. Haak, R. de Krijger, F. Porpiglia, M. Terzolo, A. Berruti, ESMO Guidelines Comm

ANNALS OF ONCOLOGY (2023)

Article Oncology

Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouse

Audrey Ziverec, Marie Chanal, Perrine Raymond, Mirela Diana Ilie, Dario De Alcubierre, Arja Pasternack, Olli Ritvos, Gerald Raverot, Philippe Bertolino

Summary: Pituitary tumours are benign neoplasms derived from hormone-producing cells of the pituitary gland. Gonadotroph tumours expressing FSH and/or luteinizing hormone lack therapeutic options apart from surgery and radiotherapy. Activin ligands play a role in FSH production but their role in gonadotroph tumourgenesis is little explored.

ENDOCRINE-RELATED CANCER (2023)

Article Endocrinology & Metabolism

Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France

Alexandre Dormoy, Magalie Haissaguerre, Geraldine Vitellius, Christine Do Cao, Aurore Geslot, Delphine Drui, Helene Lasolle, Oceana Vieira-Pinto, Sylvie Salenave, Maud Francois, Marie Puerto, Helene Du Boullay, Anne Mayer, Anne Rod, Claire Laurent, Philippe Chanson, Yves Reznik, Frederic Castinetti, Olivier Chabre, Eric Baudin, Gerald Raverot, Antoine Tabarin, Jacques Young

Summary: This study evaluated the efficacy and safety of osilodrostat in patients with PNCS/EAS in France, and found that osilodrostat had significant efficacy in reducing hypercortisolism symptoms in these patients and was generally well tolerated.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Positive Correlation Between 18F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas

Rossella Libe, Aurore Pais, Florian Violon, Laurence Guignat, Fideline Bonnet, Olivier Huillard, Guillaume Assie, Martin Gaillard, Bertrand Dousset, Sebastien Gaujoux, Maxime Barat, Anthony Dohan, Mathilde Sibony, Jerome Bertherat, Anne Segolene Cottereau, Florence Tenenbaum, Joel Coste, Lionel Groussin

Summary: This study found that most ACCs demonstrate high F-18-FDG uptake, but the positive correlation observed between SUVmax and Ki-67 expression levels seems to explain the possibility of identifying some ACCs with low or inexistent F-18-FDG uptake, which has practical implications for the management of patients with an adrenal mass.

CLINICAL NUCLEAR MEDICINE (2023)

Article Endocrinology & Metabolism

C-peptide level concomitant with hypoglycemia gives better performances than insulin for the diagnosis of endogenous hyperinsulinism: a single-center study of 159 fasting trials

Fideline Bonnet-Serrano, Clara Devin-Genteuil, Louis Thomeret, Christelle Laguillier-Morizot, Marie-Clemence Leguy, Anna Vaczlavik, Lucas Bouys, Corinne Zientek, Leopoldine Bricaire, Laura Bessiene, Laurence Guignat, Rossela Libe, Helen Mosnier-Pudar, Guillaume Assie, Lionel Groussin, Jean Guibourdenche, Jerome Bertherat

Summary: Diagnosis of endogenous hyperinsulinism relies on a hypoglycemia with low insulin and C-peptide levels. Optimized cutoffs were proposed for glycemia, insulin, and C-peptide levels for diagnosis. C-peptide level of 0.3 nmol/L with a hypoglycemia <2.3 mmol/L appears to be the best criterion for diagnosing endogenous hyperinsulinism.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome

Vincent Amodru, Amandine Ferriere, Antoine Tabarin, Frederic Castinetti, Stylianos Tsagarakis, Miklos Toth, Richard A. Feelders, Susan M. Webb, Martin Reincke, Romana Netea-Maier, Darko Kastelan, Atanaska Elenkova, Dominique Maiter, Oskar Ragnarsson, Alicia Santos, Elena Valass

Summary: This study aimed to evaluate age-related differences in clinical characteristics, diagnostic approaches, and management strategies in patients with Cushing's syndrome. Older patients had lower BMI and waist circumference, and a higher prevalence of comorbidities such as muscle weakness, diabetes, hypertension, and cardiovascular disease. They also showed different treatment preferences, with older patients more likely to receive conservative treatment and younger patients preferring surgery.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Evidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study

Kamel Mohammedi, Jerome Bertherat, Gerald Raverot, Delphine Drui, Yves Reznik, Frederic Castinetti, Philippe Chanson, Manon Fafin, Julie Brossaud, Antoine Tabarin

Summary: This study assessed the long-term cortisol exposure in medically treated Cushing disease (CD) patients by measuring the levels of hair cortisol and hair cortisone. Despite normalized urinary free cortisol levels, a subset of patients still displayed altered circadian rhythm of cortisol secretion.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports

Thi Thom Mac, Frederic Castinetti, Celine Bar, Sophie Julia, Marlene Pasquet, Pauline Romanet, Alexandru Saveanu, Gregory Mougel, Teddy Fauquier, Nicolas Jullien, Anne Barlier, Rachel Reynaud, Thierry Brue

Summary: Deficient anterior pituitary with common variable immune deficiency (DAVID) syndrome is a rare condition characterized by ACTH deficiency and primary hypogammaglobulinemia caused by NFKB2 gene mutations. A new case of DAVID syndrome was identified and a review of published cases was conducted. Early diagnosis of DAVID syndrome is important to prevent life-threatening complications.

JOURNAL OF NEUROENDOCRINOLOGY (2023)

Review Neurosciences

Current Advances in Papillary Craniopharyngioma: State-Of-The-Art Therapies and Overview of the Literature

Gianpaolo Jannelli, Francesco Calvanese, Luca Paun, Gerald Raverot, Emmanuel Jouanneau

Summary: Craniopharyngiomas are classified as low-grade tumors, but they can exhibit malignant behavior due to high recurrence rates and long-term morbidity. They are divided into two types (adamantinomatous and papillary), which are considered independent entities based on epidemiological, radiological, histopathological, and genetic patterns. Papillary craniopharyngioma frequently has a BRAF V600 mutation, which has opened new possibilities for treatment. This article presents an overview of recent literature on the specificities and the role of oncological treatment in managing papillary craniopharyngiomas.

BRAIN SCIENCES (2023)

Article Obstetrics & Gynecology

Impact of Cushing's syndrome on the gonadotrope axis and testicular functions in men

Georgios E. Papadakis, Benedicte de Kalbermatten, Alexandre Dormoy, Sylvie Salenave, Severine Trabado, Oceana Vieira-Pinto, Carine Richa, Peter Kamenicky, Philippe Chanson, Luigi Maione, Nelly Pitteloud, Jacques Young

Summary: Cushing's syndrome (CS) affects the gonadotrope axis and testicular functions differently depending on the intensity of hypercortisolism and underlying etiology. Excess cortisol caused by CS leads to varying degrees of hypogonadotropic hypogonadism (HH), with more severe impairment in men with intense hypercortisolism associated with paraneoplastic/ectopic adrenocorticotrophic hormone (ACTH) secretion (EAS).

HUMAN REPRODUCTION (2023)

Editorial Material Medicine, General & Internal

Thirty Years of Progress Thanks to the RET Oncogene

Frederic Castinetti, Francoise Borson-Chazot

Summary: Medullary thyroid cancer, although a rare form of thyroid cancer, is significant due to its phenotypic heterogeneity and aggressive behavior, as well as the lack of curative postoperative treatment. About 25% of cases are associated with the genetic tumor syndrome MEN-2, and the first drug targeting the RET gene pathway has been recognized on the 30th anniversary of its discovery.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Environmental Sciences

Does prenatal exposure to multiple airborne and tap-water pollutants increase neonatal thyroid-stimulating hormone concentrations? Data from the Picardy region, France

Sylvain Chamot, Abdallah Al-Salameh, Pascal Petit, Vincent Bonneterre, Christophe Cance, Guillaume Decocq, Agnes Boullier, Karine Braun, Rachel Desailloud

Summary: Systematic screening for congenital hypothyroidism in Picardy, France revealed unexpected heterogeneity in the geographic distribution of newborn thyroid-stimulating hormone concentrations, potentially related to environmental pollutants.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

暂无数据